Scientists Urge Transparency on Vaccines to Increase Public Trust.

The article discusses drug companies' lack of transparency on their vaccine clinical trials as of September 14, 2020. Topics covered include companies' standard of withholding trial details before completion, and their guarding of intellectual property and competitive edge. Also noted are the views of scientists and public health experts that American taxpayers should be apprised on vaccine status since the government has committed billions of dollars in vaccine research and purchase.